102 related articles for article (PubMed ID: 3023504)
1. [Phase II study of etoposide (NK 171) in trophoblastic disease. Study Group on Etoposide (NK 171) for Trophoblastic Disease].
Takeuchi S; Kanazawa K; Ichinoe K; Takamizawa H; Ishige H; Soma H; Akiya K; Hachiya S; Kawashima Y; Maeda M
Nihon Gan Chiryo Gakkai Shi; 1986 Jul; 21(6):1266-76. PubMed ID: 3023504
[No Abstract] [Full Text] [Related]
2. Oral etoposide in gestational trophoblastic disease.
Wong LC; Choo YC; Ma HK
Cancer Treat Rep; 1984 May; 68(5):775-7. PubMed ID: 6327035
[TBL] [Abstract][Full Text] [Related]
3. Etoposide.
N Engl J Med; 1985 Aug; 313(8):518-9. PubMed ID: 2991763
[No Abstract] [Full Text] [Related]
4. Use of oral VP16-213 as primary chemotherapeutic agent in treatment of gestational trophoblastic disease.
Wong LC; Choo YC; Ma HK
Am J Obstet Gynecol; 1984 Dec; 150(8):924-7. PubMed ID: 6095666
[TBL] [Abstract][Full Text] [Related]
5. Hepatic metastases in gestational trophoblastic disease.
Wong LC; Choo YC; Ma HK
Obstet Gynecol; 1986 Jan; 67(1):107-11. PubMed ID: 2999663
[TBL] [Abstract][Full Text] [Related]
6. [Etoposide (VP-16) in gynecologic malignancy].
Kanazawa K; Moromizato H
Gan To Kagaku Ryoho; 1996 Dec; 23(14):1925-8. PubMed ID: 8978799
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in gestational trophoblastic disease.
Schorge JO; Goldstein DP; Bernstein MR; Berkowitz RS
J Reprod Med; 2000 Sep; 45(9):692-700. PubMed ID: 11027078
[TBL] [Abstract][Full Text] [Related]
8. High-risk metastatic gestational trophoblastic disease. A new dose-intensive, multiagent chemotherapeutic regimen.
Surwit EA; Childers JM
J Reprod Med; 1991 Jan; 36(1):45-8. PubMed ID: 1848900
[TBL] [Abstract][Full Text] [Related]
9. Fertility in patients with gestational trophoblastic tumors treated with etoposide.
Adewole LF; Rustin GJ; Newlands ES; Dent J; Bagshawe KD
Eur J Cancer Clin Oncol; 1986 Dec; 22(12):1479-82. PubMed ID: 3036533
[TBL] [Abstract][Full Text] [Related]
10. Etoposide-platin combination therapy for chemorefractory gestational trophoblastic disease.
Soper JT; Evans AC; Rodriguez G; Berchuck A; Clarke-Pearson DL; Hammond CB
Gynecol Oncol; 1995 Mar; 56(3):421-4. PubMed ID: 7705678
[TBL] [Abstract][Full Text] [Related]
11. Single-agent chemotherapy for nonmetastatic gestational trophoblastic neoplasia. Perspectives for the 21st century after three decades of use.
Kohorn EI
J Reprod Med; 1991 Jan; 36(1):49-55. PubMed ID: 1848901
[TBL] [Abstract][Full Text] [Related]
12. [Metastatic trophoblastic disease treated with actinomycin D].
Márquez J; Martínez L; Hasbun J; Dabancens A
Rev Chil Obstet Ginecol; 1975; 40(4):173-80. PubMed ID: 184497
[No Abstract] [Full Text] [Related]
13. Persistent gestational trophoblastic disease: results of MEA (methotrexate, etoposide and dactinomycin) as first-line chemotherapy in high risk disease and EA (etoposide and dactinomycin) as second-line therapy for low risk disease.
Dobson LS; Lorigan PC; Coleman RE; Hancock BW
Br J Cancer; 2000 May; 82(9):1547-52. PubMed ID: 10789722
[TBL] [Abstract][Full Text] [Related]
14. The ICE regimen (ifosfamide, carboplatin, etoposide) for the treatment of germ-cell tumors and metastatic trophoblastic disease.
Lotz JP; André T; Bouleuc C; Péne F; Gattegno B; Bazelly B; Houry S; Chapiro J; Selle F; Gligorov J; Izrael V
Bone Marrow Transplant; 1996 Sep; 18 Suppl 1():S55-9. PubMed ID: 8899175
[No Abstract] [Full Text] [Related]
15. Chemotherapy-resistant gestational trophoblastic neoplasia treated successfully with cisplatin, etoposide, and bleomycin.
Willemse PH; Aalders JG; Bouma J; Sleijfer DT
Obstet Gynecol; 1988 Mar; 71(3 Pt 2):438-40. PubMed ID: 2450325
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate monotherapy for high-risk gestational trophoblastic neoplasia after therapy with etoposide, methotrexate, and dactinomycin: a case report.
Taran A; Ignatov A; Smith B; Bischoff J; Costa SD
Am J Obstet Gynecol; 2008 Nov; 199(5):e6-8. PubMed ID: 18984073
[TBL] [Abstract][Full Text] [Related]
17. Management of resistant gestational trophoblastic tumors.
Newlands ES; Bower M; Holden L; Short D; Seckl MJ; Rustin GJ; Begent RH; Bagshawe KD
J Reprod Med; 1998 Feb; 43(2):111-8. PubMed ID: 9513872
[TBL] [Abstract][Full Text] [Related]
18. Reproductive status in GTD treated with etoposide.
Matsui H; Seki K; Sekiya S; Takamizawa H
J Reprod Med; 1997 Feb; 42(2):104-10. PubMed ID: 9058346
[TBL] [Abstract][Full Text] [Related]
19. Alternating weekly chemotherapy with etoposide-methotrexate-dactinomycin/cyclophosphamide-vincristine for high-risk gestational trophoblastic disease.
Soper JT; Evans AC; Clarke-Pearson DL; Berchuck A; Rodriguez G; Hammond CB
Obstet Gynecol; 1994 Jan; 83(1):113-7. PubMed ID: 8272290
[TBL] [Abstract][Full Text] [Related]
20. Placental site trophoblastic tumor: an overview.
Bonazzi C; Urso M; Dell'Anna T; Sacco S; Buda A; Cantú MG
J Reprod Med; 2004 Aug; 49(8):585-8. PubMed ID: 15457847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
